Return
Eleven questions on Hantavirus cardiopulmonary syndrome management in the ICU
N
P
M
J
L
E
A
DOI:10.1186/s13054-026-06233-0.png)
Abstract
En 中文
Hantavirus cardiopulmonary syndrome (HCPS) due to Andes virus (ANDV) is a fulminant yet potentially reversible cause of respiratory and circulatory failure requiring timely critical care. This article addresses eleven practical questions on ICU management, drawing on clinical experience and research from the Chilean healthcare system. The recommendations cover early recognition, diagnostic workup, haemodynamic monitoring, cautious fluid and vasoactive support, respiratory management, VA-ECMO referral, daily ICU care, recovery, common pitfalls, and therapies with limited evidence. Because no antiviral or immunomodulatory therapy has consistently improved outcomes, survival relies on early suspicion, physiology-guided supportive care, and rapid escalation to ECMO-capable centres when severe cardiopulmonary failure develops.
Keywords:
Hantavirus
Cardiopulmonary syndrome
Intensive care unit
Extracorporeal membrane oxygenation
Andes virus
Critical care
Journal
IF:
9.3
Papers:
1.0W
Citations:
3.8W
